RCT 200 long-COVID patients in India, 100 treated with ImmunoSEB and ProbioSEB CSC3, showing improved recovery of post-COVID-19 fatigue with treatment. CTRI/2021/05/033576.
The immune effects of probiotics are strain-specific.
risk of no recovery, 89.4% lower, RR 0.11, p < 0.001, treatment 9 of 100 (9.0%), control 85 of 100 (85.0%), NNT 1.3, day 14, fatigue.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Rathi et al., 8/30/2021, Double Blind Randomized Controlled Trial, placebo-controlled, India, South Asia, peer-reviewed, 3 authors, trial CTRI/2021/05/033576.
Contact:
akrathi@advancedenzymes.com (corresponding author), swati@advancedenzymes.com, drnehashah772@gmail.com.